Analysts expect over 2018 rising revenue Sartorius

Tomorrow the German Sartorius will publish its past quarters figures. Over the current book year the total revenue will be 1,7 billion euros (consensus estimates). This is slightly more than 2017's revenue of 1,57 billion euros.

Historical revenues and results Sartorius plus estimates 2018

The analysts expect for 2018 a net profit of 175 million euros. Most of the analysts anticipate on a profit per share of 2,72 euros. With this the price/earnings-ratio is an extreme 53,13.

Analysts expect a dividend of 0,67 cents per share. Sartorius's dividend yield thus equals 0,46 percent. The average dividend yield of the biotech companies is a low 0,5 percent.

Most recent target prices around 115 euros

The latest 3 recommendations for the biotech company were provided by Deutsche Bank, Berenberg and Nord Landesbank.

Based on the current number of outstanding shares Sartorius's market capitalization is 4,94 billion euros. The Sartorius stock was the past 12 months quite volatile. Since last April the stock is even 28 percent higher. This year the stock price moved between 90 and 150 euro. Since 2008 the stock price is almost 3703 percent higher.

At 10.18 the stock trades 5,19 percent lower at 144,5 euros.

Historical stock prices Sartorius

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.